Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.37 Billion CNY | 3.75% |
| 2022 | 3.25 Billion CNY | 0.17% |
| 2021 | 3.24 Billion CNY | 544.54% |
| 2020 | 503.97 Million CNY | 143.39% |
| 2019 | 207.06 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.48 Billion CNY | 3.28% |
| 2024 Q2 | 3.48 Billion CNY | 0.0% |
| 2023 Q2 | 3.29 Billion CNY | 0.0% |
| 2023 FY | 3.37 Billion CNY | 3.75% |
| 2023 Q4 | 3.37 Billion CNY | 0.0% |
| 2023 Q3 | 3.37 Billion CNY | 2.38% |
| 2023 Q1 | 3.29 Billion CNY | 1.33% |
| 2022 Q2 | 3.23 Billion CNY | 0.0% |
| 2022 Q1 | 3.23 Billion CNY | -0.4% |
| 2022 FY | 3.25 Billion CNY | 0.17% |
| 2022 Q4 | 3.25 Billion CNY | 0.0% |
| 2022 Q3 | 3.25 Billion CNY | 0.57% |
| 2021 Q2 | 975.37 Million CNY | 0.0% |
| 2021 Q4 | 3.24 Billion CNY | 0.0% |
| 2021 Q3 | 3.24 Billion CNY | 233.03% |
| 2021 Q1 | 975.37 Million CNY | 93.54% |
| 2021 FY | 3.24 Billion CNY | 544.54% |
| 2020 FY | 503.97 Million CNY | 143.39% |
| 2020 Q4 | 503.97 Million CNY | 0.0% |
| 2020 Q3 | 503.97 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2019 FY | 207.06 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Vincent Medical Holdings Limited | 786.6 Million HKD | -329.146% |